Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joël Depondt is active.

Publication


Featured researches published by Joël Depondt.


Journal of Clinical Oncology | 2004

Hyperbaric Oxygen Therapy for Radionecrosis of the Jaw: A Randomized, Placebo-Controlled, Double-Blind Trial From the ORN96 Study Group

Djillali Annane; Joël Depondt; Philippe Aubert; Maryvonne Villart; Pierre Gehanno; Philippe Gajdos; Sylvie Chevret

PURPOSE To determine the efficacy and safety of hyperbaric oxygen therapy (HBO) for overt mandibular osteoradionecrosis. PATIENTS AND METHODS This prospective, multicenter, randomized, double-blind, placebo-controlled trial was conducted at 12 university hospitals. Ambulatory adults with overt osteoradionecrosis of the mandible were assigned to receive 30 HBO exposures preoperatively at 2.4 absolute atmosphere for 90 minutes or a placebo, and 10 additional HBO dives postoperatively or a placebo. The main outcome measure was 1-year recovery rate from osteoradionecrosis. Secondary end points included time to treatment failure, time to pain relief, 1-year mortality rate, and treatment safety. RESULTS At the time of the second interim analysis, based on the triangular test, the study was stopped for potentially worse outcomes in the HBO arm. A total of 68 patients were enrolled and analyzed. At 1 year, six (19%) of 31 patients had recovered in the HBO arm and 12 (32%) of 37 in the placebo arm (relative risk = 0.60; 95% CI, 0.25 to 1.41; P = .23). Time to treatment failure (hazard ratio = 1.33; 95% CI, 0.68 to 2.60; P = .41) and time to pain relief (hazard ratio = 1.00; 95% CI, 0.52 to 1.89; P = .99) were similar between the two treatment arms. CONCLUSION Patients with overt mandibular osteoradionecrosis did not benefit from hyperbaric oxygenation.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2005

MAJOR HEALING OF REFRACTORY MANDIBLE OSTEORADIONECROSIS AFTER TREATMENT COMBINING PENTOXIFYLLINE AND TOCOPHEROL: A PHASE II TRIAL

Sylvie Delanian; Joël Depondt; Jean-Louis Lefaix

Osteoradionecrosis (ORN) is a nonhealing wound of the bone that is difficult to manage. Is a treatment combining pentoxifylline (PTX) and tocopherol (vitamin E) boosted by clodronate effective in reversing this fibronecrotic process?


Laryngoscope | 2000

Prognostic Value of Lymph Node Involvement in Oral Cancers: A Study of 137 Cases

Frédéric Tankéré; Anne Camproux; Beatrix Barry; Charles Guedon; Joël Depondt; Pierre Gehanno

Objective The aim of this study was to assess the prognostic value of lymph node involvement in patients with squamous cell carcinoma of the oral cavity.


Human Pathology | 2003

Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters

Silvana Papagerakis; Al Hassan Shabana; Joël Depondt; Pierre Gehanno; Nadine Forest

Plakophilins (PKPs) are members of the armadillo multigene family. Armadillo-related proteins function in both cell adhesion and signal transduction, and also play a central role in tumorigenesis. Here we report the immunohistochemical localization of PKPs in 37 cases of human primary squamous cell carcinoma of the oropharynx lacking overt distant metastases that were followed clinically for 3 years. Immunoreactivity for the PKPs PKP1, PKP2, PKP3, and p0071 (also known as PKP4) was assessed on frozen unfixed sections using a semiquantitative scoring system. Results were correlated with tumor grade, clinicopathologic parameters, and patient survival. Only p0071 was associated with tumor growth, demonstrating an inverse correlation with tumor size. PKP1 and PKP3 immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize. In contrast, strong PKP2 immunoreactivity was observed in 85.7% of metastatic tumors. Interestingly, patients with tumors in which PKP1 and PKP3 immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival. Correlation of the subcellular localization of PKPs with routine histological and clinical parameters suggests that these proteins may serve as useful markers for predicting the clinical outcome of the disease. Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis. Nevertheless, the mechanisms involved in altering the subcellular localization in tumors compared with normal epithelium are unknown, and further investigation is needed to determine whether PKPs are causative factors for oral carcinogenesis or are merely characteristic of the phenotype.


Laryngoscope | 1992

Advanced carcinoma of the tongue: Total glossectomy without total laryngectomy. review of 80 cases

Pierre Gehanno; Charles Guedon; Béatrice Barry; Joël Depondt; Chedly Kebaili

Opinions are divided over the validity of total glossectomy without associated total laryngectomy for advanced carcinoma of the tongue. This retrospective study evaluates the oncologic and functional results obtained in 80 patients who underwent total glossectomy as a primary procedure or as salvage surgery. Satisfactory swallowing ability was obtained in 41 patients, and speech was understandable in 49 patients. The survival rate at 1 year was 65%, with early recurrence of the disease, which was especially frequent in patients with prior radiotherapy, being the major cause of death. The study confirms the poor prognosis of cases with mandibular involvement, and the fact that partial laryngectomy, when required, impairs functional results.


Human Pathology | 2009

Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer

Silvana Papagerakis; Al Hassan Shabana; Brad H. Pollock; Petros Papagerakis; Joël Depondt; Ariane Berdal

Desmoplakin, a desmosomal component, is a key protein involved in cell-cell adhesion. Down-regulation of desmosomal proteins is associated with the invasive and metastatic ability of tumor cells. We examined 37 cases of human primary oropharyngeal squamous cell carcinomas lacking overt distant metastases to gain further insights on the potential role of desmoplakin in oral cancer. Desmoplakin expression was evaluated using reverse transcriptase-polymerase chain reaction and immunohistochemistry on frozen unfixed sections. Western blotting was performed to characterize the relative expression levels for each of the 2 desmoplakin protein isoforms, I and II. Desmoplakin expression was compared with histopathological grade, clinical stage, and patient outcome. Desmoplakin expression was prominent in highly differentiated tumors and reduced or absent in poorly differentiated tumors that developed distant metastases within the 3 years of follow-up period. Desmoplakin mRNA levels tracked with protein levels, suggesting that lack of desmoplakin protein expression is due to down-regulation of mRNA expression at the transcription level. Western blot analysis demonstrated that the 2 desmoplakin isoforms displayed different patterns of subcellular distribution in tumors, with the desmoplakin II detected only in patients in which desmoplakin immunoreactivity displayed an abnormal cytoplasmic localization. Our findings suggest that down-regulation of desmoplakin expression may represent a useful marker for evaluating the risk of distant metastasis formation in oropharyngeal squamous cell carcinomas. Interestingly, desmoplakin II was detected only in tumors associated with a poor clinical outcome, suggesting a potential specific function for this isoform in oral carcinogenesis. Characterizing DSP expression may improve evaluation risk of distant metastasis formation in oral cancer patients.


Laryngoscope | 2003

Total Glossectomy Without Laryngectomy as First-Line or Salvage Therapy

Beatrix Barry; Bertrand Baujat; Sebastien Albert; Emmanuel Nallet; Joël Depondt; Charles Guedon; Pierre Gehanno

Objectives/Hypothesis Advanced carcinoma of the tongue can require total glossectomy. Although radiation therapy is of limited efficacy in T3 and T4 tumors involving the base of the tongue, many surgeons are reluctant to suggest highly mutilating surgery.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1996

Lateral supraglottic pharyngo-laryngectomy with arytenoidectomy

Pierre Gehanno; Beatrix Barry; Charles Guedon; Joël Depondt

Supraglottic laryngectomy for tumors of the epilarynx requiring arytenoid cartilage resection is frequently associated with problems in relearning to swallow, and aspiration is frequent. We propose a surgical procedure in which a local flap is used to close the pharyngeal defect.


Human Pathology | 2008

Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications

Joël Depondt; El-Hassan Shabana; Francine Walker; Frédéric Lézot; Ariane Berdal

Nasal inverted papilloma is a rare benign tumor of epithelial origin with aggressive evolution, bone destruction, recurrence, and malignant transformation. Msx2 is a homeobox gene implicated in organ development, bone metabolism, and tumorigenesis. Using reverse transcriptase-polymerase chain reaction and immunohistochemistry, Msx2 expression was examined in nasal inverted papilloma and in nontumorigenic tissue counterparts. For the first time, Msx2 was detected in all inverted papillomas but not in the nasal polyps or in the normal mucosa. The protein expression level was directly and significantly associated with tumor recurrence. Furthermore, Msx2 was associated with bone resorption markers receptor activator of nuclear factor-kappa B ligand and tartrate-resistant acid phosphatase, suggesting a role in osteolysis. In conclusion, Msx2 expression may represent a useful prognostic marker in inverted papilloma.


EMC - Cirugía Otorrinolaringológica y Cervicofacial | 2000

Cirugía de las celulitis cervicomediastínicas

Pierre Gehanno; Joël Depondt

Resumen Las celulitis cervicomediastinicas son la consecuencia de una inoculacion septica de la cavidad bucal o de la orofaringe. Habitualmente estas infecciones son mixtas aeroanaerobias. Pueden diferenciarse dos formas clinicas: la forma mionecrotica, con gangrena gaseosa de extension extremadamente rapida, y la forma seudoflemonosa de evolucion mas lenta. El tratamiento del paciente consiste en su traslado a la unidad de cuidados intensivos, la realizacion de una tomografia computadorizada cervicotoracica (si es posible), intubacion y antibioticoterapia que abarque los germenes aerobios y anaerobios. Si bien en la forma gangrenosa la indicacion quirurgica es evidente, en las formas seudoflemonosas depende de los signos de gravedad generales y hemodinamicos. Consiste en una cervicotomia amplia que permita la abertura de todas las cavidades anatomicas, localizacion de las zonas de supuracion y toma de muestras bacteriologicas, escision de los tejidos necroticos hasta llegar a los tejidos sanos. Durante la operacion debe explorarse sistematicamente la comunicacion cervicotoracica. Despues del lavado, se deja un drenaje amplio, haciendo una simple aposicion del colgajo cutaneo sobre la region cervical. Al dia siguiente de la operacion se cambia el aposito bajo anestesia general, si la necrosis continua se efectuan nuevas resecciones histicas, la mejoria del estado local permitira la colocacion de apositos simples en reanimacion. La decision de cierre hermetico de la piel cervical dependera de la mejoria del estado local y general. Siempre se debera considerar una posible toracotomia en caso de que se produzca una complicacion mediastinica septica.

Collaboration


Dive into the Joël Depondt's collaboration.

Top Co-Authors

Avatar

Pierre Gehanno

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

El-Hassan Shabana

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge